Particularly, among the top 14 TFs, four (SR1, FOXA1, FOXC1, MYBL2) were among the TFs of the PAM50 gene signature (p = 1.46E-7, hypergeometric test), further indicating their role in regulatory mechanisms of breast cancer subtypes. This evidence concerns the gene MYBL2 and breast cancer.